Kaj Anker Jorgensen
Overview
Explore the profile of Kaj Anker Jorgensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winther S, Christensen J, Flyvbjerg A, Schmidt E, Jorgensen K, Skou-Jorgensen H, et al.
Clin Nephrol
. 2013 Apr;
80(3):161-7.
PMID: 23547804
Background: Patients treated with hemodialysis (HD) have an increased mortality, mainly caused by cardiovascular disease (CVD). Osteoprotegerin (OPG) is a glycoprotein involved in the regulation of the vascular calcification process....
2.
Idorn T, Hornum M, Bjerre M, Jorgensen K, Thomsen Nielsen F, Hansen J, et al.
Transpl Int
. 2012 Sep;
25(11):1194-203.
PMID: 22994569
The role of plasma adiponectin (ADPN) in patients with impaired kidney function and following kidney transplantation (Tx) is debated. We aimed to: (i) determine whether pretransplant ADPN level is an...
3.
Magnusson N, Hornum M, Jorgensen K, Hansen J, Bistrup C, Feldt-Rasmussen B, et al.
BMC Nephrol
. 2012 Feb;
13:8.
PMID: 22325322
Background: Neutrophil gelatinase associated lipocalin (NGAL) is a biomarker of kidney injury. We examined plasma levels of NGAL in a cohort of 57 kidney allograft recipients (Tx group, 39 ±...
4.
Ozbay L, Moller N, Juhl C, Bjerre M, Carstens J, Rungby J, et al.
Br J Clin Pharmacol
. 2011 Oct;
73(4):536-45.
PMID: 21988494
What Is Already Known About This Subject: New onset diabetes after transplantation is related to treatment with immunosuppressive medications. Clinical studies have shown that risk of new onset diabetes is...
5.
Kirkegaard E, Svensson M, Strandhave C, Schmidt E, Jorgensen K, Christensen J
Br J Nutr
. 2011 Jul;
107(6):903-9.
PMID: 21791142
Patients treated with haemodialysis are at high risk of sudden cardiac death (SCD) often caused by arrhythmias. Atrial fibrillation (AF) is frequent among haemodialysis patients and is associated with increased...
6.
Svensson M, Jorgensen K, Christensen J
Am J Kidney Dis
. 2011 Jan;
57(2):352.
PMID: 21251545
No abstract available.
7.
Alstrup K, Kangas I, Lund Laursen A, Jorgensen K
Scand J Urol Nephrol
. 2011 Jan;
45(3):216-9.
PMID: 21222566
The introduction of highly active antiretroviral therapy in the mid-1990s led to a dramatic reduction in mortality and progression to AIDS, and human immunodeficiency virus (HIV)infection has now turned into...
8.
Hornum M, Jorgensen K, Hansen J, Thomsen Nielsen F, Christensen K, Mathiesen E, et al.
Clin J Am Soc Nephrol
. 2010 Feb;
5(4):709-16.
PMID: 20167685
Background And Objectives: This study aimed to investigate the development of new-onset diabetes mellitus (NODM) in a prospective study of 97 nondiabetic uremic patients. Design, Setting, Participants, & Measurements: Included...
9.
Ozbay A, Karamperis N, Jorgensen K
Curr Clin Pharmacol
. 2008 Aug;
2(3):244-8.
PMID: 18690871
Cyclosporine A (CsA) is metabolized into a vast spectrum of metabolites. The potential immunosuppressive action of CsA's metabolites has been studied extensively in the early 1990's, with conflicting and inconclusive...
10.
Larsen T, Hammer A, Jorgensen K
Scand J Urol Nephrol
. 2007 Sep;
42(2):187-8.
PMID: 17853051
A 51-year-old male with a history of chronic renal disease received a renal allograft, in which disease recurred. Light-chain deposition disease was confirmed through biopsies of the native kidney and...